Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Sarcopenia affects clinical efficacy of immune checkpoint inhibitors in non-small cell lung cancer patients: A systematic review and meta-analysis
Jiajun Wang, Liu Cao, Shun Xu
International Immunopharmacology (2020) Vol. 88, pp. 106907-106907
Closed Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

Sarcopenia: An underlying treatment target during the COVID-19 pandemic
Peiyu Wang, Yin Li, Qin Wang
Nutrition (2020) Vol. 84, pp. 111104-111104
Open Access | Times Cited: 93
Predictive impact of sarcopenia in solid cancers treated with immune checkpoint inhibitors: a meta‐analysis
Yukinori Takenaka, Ryohei Oya, Norihiko Takemoto, et al.
Journal of Cachexia Sarcopenia and Muscle (2021) Vol. 12, Iss. 5, pp. 1122-1135
Open Access | Times Cited: 89
Effect of Cancer-Related Cachexia and Associated Changes in Nutritional Status, Inflammatory Status, and Muscle Mass on Immunotherapy Efficacy and Survival in Patients with Advanced Non-Small Cell Lung Cancer
Clelia Madeddu, Sı́lvia Busquets, Clelia Donisi, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1076-1076
Open Access | Times Cited: 30
Associations of subcutaneous fat area and Systemic Immune-inflammation Index with survival in patients with advanced gastric cancer receiving dual PD-1 and HER2 blockade
He Meng, Zifan Chen, Li Zhang, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 6, pp. e007054-e007054
Open Access | Times Cited: 26
Impact of sarcopenia on the prognosis and treatment of lung cancer: an umbrella review
Ting-Yu Lin, Yen‐Fu Chen, Wei‐Ting Wu, et al.
Discover Oncology (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 33
Survival and immunotoxicities in association with sex-specific body composition patterns of cancer patients undergoing immune-checkpoint inhibitor therapy – A systematic review and meta-analysis
Paul Trinkner, Sophie Günther, Ina Monsef, et al.
European Journal of Cancer (2023) Vol. 184, pp. 151-171
Closed Access | Times Cited: 19
Geriatric nutritional risk index as an easy‐to‐use assessment tool for nutritional status in hepatocellular carcinoma treated with atezolizumab plus bevacizumab
Atsushi Hiraoka, Takashi Kumada, Toshifumi Tada, et al.
Hepatology Research (2023) Vol. 53, Iss. 10, pp. 1031-1042
Open Access | Times Cited: 17
Prognostic Impact of Sarcopenia on Clinical Outcomes in Malignancies Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
Shuluan Li, Tianyu Wang, Gangling Tong, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 41
Sarcopenia as a risk factor of progression-free survival in patients with metastases: a systematic review and meta-analysis
Lingli Luo, Xiangru Shen, Shuai Fang, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 15
Good performance of the Global Leadership Initiative on Malnutrition criteria for diagnosing and classifying malnutrition in people with esophageal cancer undergoing esophagectomy
Peiyu Wang, Xiankai Chen, Qi Liu, et al.
Nutrition (2021) Vol. 91-92, pp. 111420-111420
Closed Access | Times Cited: 29
Associations between Pretreatment Body Composition Features and Clinical Outcomes among Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Immune Checkpoint Blockade
Yasser Ged, Alejandro Sánchez, Sujata Patil, et al.
Clinical Cancer Research (2022) Vol. 28, Iss. 23, pp. 5180-5189
Open Access | Times Cited: 21
Oncology-Led Early Identification of Nutritional Risk: A Pragmatic, Evidence-Based Protocol (PRONTO)
Maurizio Muscaritoli, Gil Bar‐Sela, Nicolò Matteo Luca Battisti, et al.
Cancers (2023) Vol. 15, Iss. 2, pp. 380-380
Open Access | Times Cited: 11
Impact of Sarcopenia and Inflammation on Patients with Advanced Non-Small Cell Lung Cancer (NCSCL) Treated with Immune Checkpoint Inhibitors (ICIs): A Prospective Study
Marta Tenuta, Alain Gelibter, Carla Pandozzi, et al.
Cancers (2021) Vol. 13, Iss. 24, pp. 6355-6355
Open Access | Times Cited: 26
Lower-extremity muscle strength is associated with prognosis in patients with advanced or recurrent lung cancer: a retrospective, observational study
Takuya Fukushima, Utae Katsushima, Naoya Ogushi, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Analysis of clinical factors and inflammatory cytokines in patients with lung cancer and sarcopenia: a prospective single-center cohort study
Yalan Liu, Hui Zhang, Peng Chen, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Body composition derangements in lung cancer patients treated with first‐line pembrolizumab: A multicentre observational study
Ilaria Trestini, Lorenzo Belluomini, Alessandra Dodi, et al.
Journal of Cachexia Sarcopenia and Muscle (2024) Vol. 15, Iss. 6, pp. 2349-2360
Open Access | Times Cited: 3
GLIM diagnosed malnutrition predicts clinical outcomes and quality of life in patients with non-small cell lung cancer
Maria Landgrebe, Randi Tobberup, Andreas Carus, et al.
Clinical Nutrition (2022) Vol. 42, Iss. 2, pp. 190-198
Closed Access | Times Cited: 14
Sarcopenia in Lung Cancer: A Narrative Review
Uzair Jogiat, Zaharadeen Jimoh, Simon R. Turner, et al.
Nutrition and Cancer (2023) Vol. 75, Iss. 7, pp. 1485-1498
Closed Access | Times Cited: 8
Artificial Intelligence and Radiomics: Clinical Applications for Patients with Advanced Melanoma Treated with Immunotherapy
Jeremy McGale, Jakob Hama, Randy Yeh, et al.
Diagnostics (2023) Vol. 13, Iss. 19, pp. 3065-3065
Open Access | Times Cited: 8
Immune Checkpoint Inhibitors and the Exposome: Host-Extrinsic Factors Determine Response, Survival, and Toxicity
Elio Gregory Pizzutilo, Rebecca Romanò, Laura Roazzi, et al.
Cancer Research (2023) Vol. 83, Iss. 14, pp. 2283-2296
Open Access | Times Cited: 7
Effects of Exercise Training on Muscle Quality in Older Individuals: A Systematic Scoping Review with Meta-Analyses
Tibor Hortobágyi, Tomáš Větrovský, Jennifer S. Brach, et al.
Sports Medicine - Open (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 6
Sarcopenia is associated with chemoradiotherapy discontinuation and reduced progression-free survival in glioblastoma patients
Fabian M. Troschel, Benjamin O. Troschel, Maren Kloss, et al.
Strahlentherapie und Onkologie (2024) Vol. 200, Iss. 9, pp. 774-784
Open Access | Times Cited: 2
Sarcopenia’s Prognostic Impact on Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
Donggun Lee, Na Won Kim, Jong Yeob Kim, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 22, pp. 5329-5329
Open Access | Times Cited: 13
Sarcopenia as a Determinant of the Efficacy of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: A Meta-Analysis
Bixin Ren, Jiucheng Shen, Yajuan Qian, et al.
Nutrition and Cancer (2022) Vol. 75, Iss. 2, pp. 685-695
Open Access | Times Cited: 10
Body composition as a modulator of response to immunotherapy in lung cancer: time to deal with it
Ilaria Trestini, Alberto Caldart, Alessandra Dodi, et al.
ESMO Open (2021) Vol. 6, Iss. 2, pp. 100095-100095
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top